CERAGON NETWORKS LTD·4

May 26, 8:11 AM ET

Rosen Ilan 4

4 · CERAGON NETWORKS LTD · Filed May 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Ceragon (CRNT) Director Ilan Rosen Receives RSUs and Options

What Happened
Ilan Rosen, a director of Ceragon Networks Ltd. (CRNT), was awarded equity compensation in late May 2026. The filing shows 9,770 RSUs settled into shares on 05/22/2026 and 22,120 RSUs settled into shares on 05/23/2026 (total 31,890 shares acquired). In addition, Rosen was granted stock options on 05/22/2026 (19,540 options) and 05/23/2026 (44,240 options) — 63,780 options in total. All items were reported with $0 consideration. The RSUs were fully vested and automatically converted to ordinary shares on grant; the options were granted fully vested and immediately exercisable. These entries are awards/grants (compensation), not open‑market purchases or sales.

Key Details

  • Transaction dates: RSU settlements 05/22/2026 (9,770) and 05/23/2026 (22,120); option grants 05/22/2026 (19,540) and 05/23/2026 (44,240).
  • Consideration reported: $0.00 for all grants.
  • Shares acquired via RSU settlement: 31,890 shares. Options granted (derivative): 63,780 options (fully vested/exercisable on grant).
  • Shares owned after transaction: not specified in the Form 4 filing.
  • Footnotes: F1–F2 explain RSUs were vested and automatically settled into shares; F3–F4 state options were fully vested and immediately exercisable on grant.
  • Filing: Form 4 filed 05/26/2026 covering transactions on 05/22 and 05/23; the filing does not include a late‑filing notation.

Context

  • RSU settlements mean Rosen received ordinary shares as compensation (no cash outlay).
  • The options are grants (derivative securities) and are already exercisable per the filing; the filing does not show any exercises or subsequent sales.
  • Awards like these are common compensation tools and do not by themselves indicate an insider buying or selling stock in the open market.

Insider Transaction Report

Form 4
Period: 2026-05-22
Rosen Ilan
Director
Transactions
  • Award

    Ordinary Shares

    [F1]
    2026-05-22+9,77071,270 total
  • Award

    Ordinary Shares

    [F2]
    2026-05-23+22,12093,390 total
  • Award

    Stock Option (Right to Buy)

    [F3]
    2026-05-22+19,54019,540 total
    Exercise: $2.79From: 2026-05-22Exp: 2032-05-22Ordinary Shares (19,540 underlying)
  • Award

    Stock Option (Right to Buy)

    [F4]
    2026-05-23+44,24044,240 total
    Exercise: $2.80From: 2026-05-23Exp: 2032-05-23Ordinary Shares (44,240 underlying)
Footnotes (4)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Ceragon Networks Ltd. (the "Company"). The RSUs were fully vested upon grant and were automatically settled in ordinary shares on the grant date 05/22/2026.
  • [F2]The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Ceragon Networks Ltd. (the "Company"). The RSUs were fully vested upon grant and were automatically settled in ordinary shares on the grant date 05/23/2026.
  • [F3]The Reporting Person was granted stock options to purchase ordinary shares of Ceragon Networks Ltd. (the "Company"). The options were fully vested and immediately exercisable on the grant date 05/22/2026
  • [F4]The Reporting Person was granted stock options to purchase ordinary shares of Ceragon Networks Ltd. (the "Company"). The options were fully vested and immediately exercisable on the grant date 05/23/2026
Signature
/s/ Netta Cohen on behalf of Oppenheimer Israel, as Attorney-in-fact|2026-05-26

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT